An open-label, parallel-group, bioavailability study to assess the pharmacokinetics of CAT-354 following subcutaneous and intravenous administration
Phase of Trial: Phase I
Latest Information Update: 09 May 2017
At a glance
- Drugs Tralokinumab; Tralokinumab
- Indications Asthma
- Focus Pharmacokinetics
- Sponsors MedImmune
- 19 May 2009 Results reported at the 105th International Conference of the American Thoracic Society.
- 15 Apr 2008 Dosing has begun according to a MedImmune media release.
- 15 Apr 2008 Status changed from initiated to recruiting according to a MedImmune media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History